Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma A Phase II Study

NCT04682158 is registered in ClinicalTrials.gov with Roswell Park Cancer Institute as lead sponsor.

NCT NCT04682158
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04682158 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma A Phase II Study
Lead sponsor
Roswell Park Cancer Institute
Phase
Phase 2
Overall status
Recruiting
Start date
April 1, 2021
Completion date
April 1, 2029
Enrollment
106 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal adenocarcinoma